0001179110-21-003704.txt : 20210322
0001179110-21-003704.hdr.sgml : 20210322
20210322213430
ACCESSION NUMBER: 0001179110-21-003704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210318
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHRISTOPHER RICHARD
CENTRAL INDEX KEY: 0001271244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37350
FILM NUMBER: 21762919
MAIL ADDRESS:
STREET 1: C/O LUCID, INC.
STREET 2: 50 METHODIST HILL DR, SUITE 1000
CITY: ROCHESTER
STATE: NY
ZIP: 14623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP.
CENTRAL INDEX KEY: 0001292519
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 1400 EAST 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-863-5524
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 1400 EAST 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Design Source, Inc.
DATE OF NAME CHANGE: 20040602
4
1
edgar.xml
FORM 4 -
X0306
4
2021-03-18
0
0001292519
INVIVO THERAPEUTICS HOLDINGS CORP.
NVIV
0001271244
CHRISTOPHER RICHARD
C/O INVIVO THERAPEUTICS HOLDINGS CORP.
ONE KENDALL SQUARE, SUITE B14402
CAMBRIDGE
MA
02139
0
1
0
0
CFO and Treasurer
Stock Option (right to buy)
1.10
2021-03-18
4
A
0
75000
0.00
A
2031-03-17
Common Stock
75000
75000
D
This option was granted on March 18, 2021. The shares underlying the option vest over two years, with 50% of the shares vesting on March 18, 2022 and the remaining shares vesting on March 18, 2023.
Exhibit Index: 24.1 Power of Attorney
/s/ Heather Hamel, Attorney-in-Fact
2021-03-22
EX-24
2
ex24christopher.txt
EXHIBIT 24.1
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes
and appoints each of Heather Hamel and Richard Toselli, signing singly and
each acting individually, as the undersigned's true and lawful attorney-in-fact
with full power and authority as hereinafter described to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Invivo Therapeutics Holdings Corp.
(the "Company"), Forms 3, 4, and 5 (including any amendments thereto) in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to prepare, complete and execute any such
Form 3, 4, or 5, prepare, complete and execute any amendment or amendments
thereto, and timely deliver and file such form with the United States Securities
and Exchange Commission and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information regarding transactions in the Company's
securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such
person to release any such information to such attorney-in-fact and approves and
ratifies any such release of information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming nor
relieving, nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act. The undersigned
acknowledges that neither the Company nor the foregoing attorneys-in-fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 22nd day of March, 2021.
/s/ Richard Christopher
-----------------------------------------
Signature
Richard Christopher
-----------------------------------------
Print Name